CRIS Current Research Information System

DIEMBERGER, IGOR
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 16.082
NA - Nord America 15.206
EU - Europa 12.278
SA - Sud America 983
AF - Africa 777
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 9
Totale 45.362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.007
VN - Vietnam 4.421
SG - Singapore 4.327
CN - Cina 3.791
IT - Italia 2.467
GB - Regno Unito 2.440
DE - Germania 1.798
NL - Olanda 1.294
HK - Hong Kong 1.180
SE - Svezia 830
FR - Francia 802
IN - India 741
BR - Brasile 707
RU - Federazione Russa 679
UA - Ucraina 656
KR - Corea 397
IE - Irlanda 363
JP - Giappone 283
BD - Bangladesh 258
CI - Costa d'Avorio 256
FI - Finlandia 240
ZA - Sudafrica 209
EE - Estonia 198
AR - Argentina 127
TG - Togo 112
BG - Bulgaria 99
CA - Canada 96
ID - Indonesia 96
PH - Filippine 90
CH - Svizzera 88
JO - Giordania 86
SC - Seychelles 82
AT - Austria 70
IQ - Iraq 70
MX - Messico 61
TH - Thailandia 61
PL - Polonia 54
TR - Turchia 44
PK - Pakistan 43
TW - Taiwan 39
BE - Belgio 38
NG - Nigeria 38
EC - Ecuador 37
ES - Italia 31
IR - Iran 30
SA - Arabia Saudita 28
CO - Colombia 27
GR - Grecia 27
CL - Cile 26
AU - Australia 25
PY - Paraguay 21
EG - Egitto 18
RO - Romania 18
UZ - Uzbekistan 17
VE - Venezuela 16
MA - Marocco 14
TN - Tunisia 12
LT - Lituania 11
PE - Perù 11
MY - Malesia 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
DO - Repubblica Dominicana 9
LB - Libano 9
CR - Costa Rica 8
DK - Danimarca 8
KE - Kenya 8
PT - Portogallo 8
AZ - Azerbaigian 7
JM - Giamaica 7
AL - Albania 6
EU - Europa 6
IL - Israele 6
MN - Mongolia 6
NP - Nepal 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
DZ - Algeria 5
HR - Croazia 5
HU - Ungheria 5
KZ - Kazakistan 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
NO - Norvegia 4
PR - Porto Rico 4
SI - Slovenia 4
SN - Senegal 4
AO - Angola 3
HN - Honduras 3
LU - Lussemburgo 3
SM - San Marino 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
KG - Kirghizistan 2
LK - Sri Lanka 2
Totale 45.322
Salva come PNG Salva come JPEG
Città #
Singapore 3.020
Southend 2.107
Ashburn 1.591
Fairfield 1.365
San Jose 1.218
Hong Kong 1.120
Ho Chi Minh City 964
Hefei 865
Hanoi 743
Chandler 727
Santa Clara 720
Woodbridge 670
Kerkrade 652
Wilmington 622
Seattle 585
Princeton 563
Houston 558
Dong Ket 497
Jacksonville 453
Cambridge 446
Frankfurt am Main 433
Beijing 420
Boardman 396
Dublin 363
Seoul 355
Eygelshoven 338
Lauterbourg 336
Ann Arbor 326
Los Angeles 293
Bologna 274
Abidjan 256
Tokyo 244
Council Bluffs 235
Westminster 232
Milan 214
Nanjing 211
New York 198
Padova 198
Helsinki 190
Berlin 173
Dallas 167
Rome 150
Buffalo 137
Saint Petersburg 134
Haiphong 128
Jinan 128
Da Nang 127
Shenyang 113
São Paulo 113
Lomé 112
Redondo Beach 105
Sofia 94
Medford 91
San Diego 89
Bremen 88
Changsha 87
Bengaluru 84
Turin 83
Amman 82
Mülheim 79
The Dalles 78
Guangzhou 71
Munich 70
Nanchang 68
Des Moines 64
Hebei 64
Chicago 62
Redmond 61
Bern 57
Mahé 57
Nuremberg 54
Biên Hòa 52
Tianjin 50
Shanghai 49
Zhengzhou 49
Jiaxing 47
London 45
Phoenix 44
Hải Dương 43
Jakarta 43
Naples 43
Hangzhou 41
Yubileyny 40
Can Tho 39
Olalla 38
Warsaw 36
Abeokuta 35
Bari 35
Ninh Bình 35
Brussels 34
Ningbo 34
Dearborn 33
Lappeenranta 33
Verona 33
Falkenstein 32
Amsterdam 30
Johannesburg 30
Toronto 30
Florence 29
Mexico City 29
Totale 29.179
Salva come PNG Salva come JPEG
Nome #
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 1.702
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.117
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 318
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 309
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 289
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 270
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 264
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 251
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 250
Automated CO2 angiography: Injection pressure and volume settings 242
Atrial fibrillation: it is better to be alone than in bad company! 230
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 230
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 229
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 223
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry 219
AF burden is important - Fact or fiction? 218
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 217
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 209
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 207
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 207
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 205
Electrocardiographic remodeling during cardiac resynchronization therapy 202
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 201
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 200
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 199
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 198
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 197
Farmaci antiaritmici 197
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 197
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 197
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 196
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 195
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 194
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 194
Exploring Microphone Technologies for Digital Auscultation Devices 193
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 193
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 193
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 192
Drug-induced Kounis syndrome: A matter of pharmacovigilance 189
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 186
A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS: The NARROW-CRT Study 184
Atrial fibrillation ablation: beyond electro-mechanical matters 184
Comparison Between a Single-Lead ECG Garment Device and a Holter Monitor: A Signal Quality Assessment 183
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 183
Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only? 182
Wireless Endocardial Atrial (and Ventricular) Sensing with no Implanted Power Source: a Proposal 181
Implantation of cardioverter-defibrillator: Effects on shoulder function. 179
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 178
Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients 177
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 177
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 176
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 176
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 175
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 175
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 174
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 173
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 173
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 173
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 172
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 171
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 170
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 170
Improving Auscultation in Wearable Health Devices Integrating MEMS Microphones and Accelerometers 169
Is ventricular sensing always right, when it is left? 169
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 169
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 169
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 166
Predictors of long-term survival free from relapses after extraction of infected CIED. 166
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 166
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 164
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 164
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes 163
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 162
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 161
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis 159
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 159
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 158
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 158
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 158
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 158
The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies 158
Atrial fibrillation and heart failure: does one epidemic feed he other? 157
Self-reported physical activity and major adverse events in patients with atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 157
Cardiac resynchronization therapy and cardiac sympathetic function. 156
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 155
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 153
QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study 153
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations 153
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 153
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase 153
Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria 152
The QRS interval in patients treated with resynchronization therapy: which value 152
Phrenic stimulation: a challenge for cardiac resynchronization therapy 152
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 152
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 151
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 151
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients 151
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 149
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 149
Totale 21.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.426 0 0 0 0 0 0 0 0 0 0 0 1.426
2021/20224.152 344 187 262 318 422 252 113 380 165 198 747 764
2022/20234.533 446 563 212 596 269 277 157 237 833 248 349 346
2023/20241.566 125 219 109 116 152 295 92 122 72 111 68 85
2024/20256.574 294 1.236 524 469 1.050 289 349 161 96 402 386 1.318
2025/202617.784 1.658 1.692 1.574 1.233 1.478 1.843 2.279 1.091 2.557 1.180 640 559
Totale 46.209